Antiemetic agent: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett m (Antiemetic moved to Antiemetic agent: To be consistent with NLM terminology) |
imported>Robert Badgett No edit summary |
||
Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
''' | In [[medicine]], '''antiemetic agents''' are [[medication]]s to "prevent [[nausea]] or [[vomit]]ing. Antiemetics act by a wide range of mechanisms. Some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors."<ref>{{MeSH}}</ref> | ||
In a randomized controlled trial that | In a [[randomized controlled trial]] that compared [[droperidol]], [[metoclopramide]], and [[prochlorperazine]], droperidol was more effective but also caused more self-reported [[anxiety]] or restlessness.<ref name="pmid16490647">Braude D et al. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. Am J Emerg Med. 2006 Mar;24(2):177-82. PMID 16490647</ref> | ||
==References== | ==References== | ||
<references/> | <references/> |
Revision as of 03:59, 8 March 2009
In medicine, antiemetic agents are medications to "prevent nausea or vomiting. Antiemetics act by a wide range of mechanisms. Some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors."[1]
In a randomized controlled trial that compared droperidol, metoclopramide, and prochlorperazine, droperidol was more effective but also caused more self-reported anxiety or restlessness.[2]
References
- ↑ Anonymous (2024), Antiemetic agent (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Braude D et al. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. Am J Emerg Med. 2006 Mar;24(2):177-82. PMID 16490647